Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Comoli

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|July 27, 2023
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinomaSimona Secondino, Paolo Pedrazzoli, Sabrina Basso, et al.
International Journal of Molecular Sciences|December 1, 2020
<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?Fabio Forghieri, Vincenzo Nasillo, Ambra Paolini, et al.
Cancers|October 16, 2024
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and DesignGiulia Maria Stella, Daniela Lisini, Paolo Pedrazzoli, et al.
Biomedicines|August 27, 2021
How to Improve Prognostication in Acute Myeloid Leukemia with <i>CBFB-MYH11</i> Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) MonitoringAnnalisa Talami, Francesca Bettelli, Valeria Pioli, et al.
Journal of Immunology Research|April 4, 2017
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney RecipientsMichela Cioni, Arcangelo Nocera, Annalisa Innocente, et al.
Cells|March 25, 2022
BTK Inhibitors Impair Platelet-Mediated Antifungal ActivityVincenzo Nasillo, Ivana Lagreca, Daniela Vallerini, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 20, 2022
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipientMaddalena Peghin, Nadia Castaldo, Carlo Tascini, et al.
International Journal of Hematology|August 2, 2023
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unitAndrea Gilioli, Paola Bresciani, Erica Franceschini, et al.
British Journal of Haematology|October 19, 2013
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALLGiovanni Riva, Mario Luppi, Ivana Lagreca, et al.
Annals of Neurology|January 18, 2021
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal LeukoencephalopathyGiulia Berzero, Sabrina Basso, Luca Stoppini, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|July 27, 2023
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinomaSimona Secondino, Paolo Pedrazzoli, Sabrina Basso, et al.
International Journal of Molecular Sciences|December 1, 2020
<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?Fabio Forghieri, Vincenzo Nasillo, Ambra Paolini, et al.
Cancers|October 16, 2024
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and DesignGiulia Maria Stella, Daniela Lisini, Paolo Pedrazzoli, et al.
Biomedicines|August 27, 2021
How to Improve Prognostication in Acute Myeloid Leukemia with <i>CBFB-MYH11</i> Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) MonitoringAnnalisa Talami, Francesca Bettelli, Valeria Pioli, et al.
Journal of Immunology Research|April 4, 2017
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney RecipientsMichela Cioni, Arcangelo Nocera, Annalisa Innocente, et al.
Cells|March 25, 2022
BTK Inhibitors Impair Platelet-Mediated Antifungal ActivityVincenzo Nasillo, Ivana Lagreca, Daniela Vallerini, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 20, 2022
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipientMaddalena Peghin, Nadia Castaldo, Carlo Tascini, et al.
International Journal of Hematology|August 2, 2023
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unitAndrea Gilioli, Paola Bresciani, Erica Franceschini, et al.
British Journal of Haematology|October 19, 2013
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALLGiovanni Riva, Mario Luppi, Ivana Lagreca, et al.
Annals of Neurology|January 18, 2021
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal LeukoencephalopathyGiulia Berzero, Sabrina Basso, Luca Stoppini, et al.
Pageof 14